• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

前列腺癌成像的正电子发射断层扫描最新进展

Update on positron emission tomography for imaging of prostate cancer.

作者信息

Kitajima Kazuhiro, Murphy Robert C, Nathan Mark A, Sugimura Kazuro

机构信息

Department of Radiology, Kobe University School of Medicine, Kobe, Japan.

出版信息

Int J Urol. 2014 Jan;21(1):12-23. doi: 10.1111/iju.12250. Epub 2013 Sep 1.

DOI:10.1111/iju.12250
PMID:23991644
Abstract

Prostate cancer is the most common non-cutaneous malignancy among men in the Western world, and continues to be a major health problem. Imaging has recently become more important in the clinical management of prostate cancer patients, including diagnosis, staging, choice of optimal treatment strategy, treatment follow up and restaging. Positron emission tomography, a functional and molecular imaging technique, has opened a new field in clinical oncological imaging. The most common positron emission tomography radiotracer, 18F-fluorodeoxyglucose, has been limited in imaging of prostate cancer. Recently, however, other positron emission tomography tracers, such as 11C-acetate and 11C- or (18) F-choline, have shown promising results. In the present review article, we overview the potential and current use of positron emission tomography or positron emission tomography/computed tomography imaging employing the four most commonly used positron emission tomography radiotracers, 18F-fluorodeoxyglucose, 11C-acetate and 11C- or 18F-choline, for imaging evaluation of prostate cancer.

摘要

前列腺癌是西方世界男性中最常见的非皮肤恶性肿瘤,并且仍然是一个主要的健康问题。影像学最近在前列腺癌患者的临床管理中变得更加重要,包括诊断、分期、最佳治疗策略的选择、治疗随访和重新分期。正电子发射断层扫描是一种功能和分子成像技术,在临床肿瘤学成像领域开辟了一个新领域。最常见的正电子发射断层扫描放射性示踪剂18F-氟脱氧葡萄糖在前列腺癌成像中存在局限性。然而,最近其他正电子发射断层扫描示踪剂,如11C-醋酸盐和11C-或18F-胆碱,已显示出有前景的结果。在本综述文章中,我们概述了使用四种最常用的正电子发射断层扫描放射性示踪剂,即18F-氟脱氧葡萄糖、11C-醋酸盐和11C-或18F-胆碱的正电子发射断层扫描或正电子发射断层扫描/计算机断层扫描成像在前列腺癌成像评估中的潜力和当前应用情况。

相似文献

1
Update on positron emission tomography for imaging of prostate cancer.前列腺癌成像的正电子发射断层扫描最新进展
Int J Urol. 2014 Jan;21(1):12-23. doi: 10.1111/iju.12250. Epub 2013 Sep 1.
2
Positron emission tomography and positron emission tomography/computerized tomography of urological malignancies: an update review.泌尿系统恶性肿瘤的正电子发射断层扫描及正电子发射断层扫描/计算机断层扫描:最新综述
J Urol. 2008 Jan;179(1):34-45. doi: 10.1016/j.juro.2007.08.176. Epub 2007 Nov 13.
3
Positron emission tomography in imaging evaluation of staging, restaging, treatment response, and prognosis in prostate cancer.正电子发射断层扫描在前列腺癌分期、再分期、治疗反应和预后评估中的应用。
Abdom Radiol (NY). 2016 May;41(5):889-98. doi: 10.1007/s00261-015-0563-0.
4
Value of [11C]choline-positron emission tomography for re-staging prostate cancer: a comparison with [18F]fluorodeoxyglucose-positron emission tomography.[11C]胆碱正电子发射断层扫描在前列腺癌再分期中的价值:与[18F]氟脱氧葡萄糖正电子发射断层扫描的比较。
J Urol. 2003 Apr;169(4):1337-40. doi: 10.1097/01.ju.0000056901.95996.43.
5
Recent developments in urologic oncology: positron emission tomography molecular imaging.泌尿外科肿瘤学的最新进展:正电子发射断层扫描分子成像
Curr Opin Oncol. 2008 May;20(3):321-6. doi: 10.1097/CCO.0b013e3282f8b02b.
6
Positron-emission tomography imaging in urological oncology: Current aspects and developments.泌尿外科肿瘤学中的正电子发射断层扫描成像:当前现状与进展
Int J Urol. 2018 Nov;25(11):912-921. doi: 10.1111/iju.13779. Epub 2018 Aug 13.
7
Positron-emission tomography in imaging and staging prostate cancer.正电子发射断层扫描在前列腺癌成像和分期中的应用
Cancer Biomark. 2008;4(4-5):277-84. doi: 10.3233/cbm-2008-44-509.
8
Comparison of meta-analyses among elastosonography (ES) and positron emission tomography/computed tomography (PET/CT) imaging techniques in the application of prostate cancer diagnosis.弹性超声成像(ES)与正电子发射断层扫描/计算机断层扫描(PET/CT)成像技术在前列腺癌诊断应用中的荟萃分析比较。
Tumour Biol. 2016 Mar;37(3):2999-3007. doi: 10.1007/s13277-015-4113-8. Epub 2015 Sep 29.
9
Comparison of 11C-choline with 18F-FDG in positron emission tomography/computerized tomography for staging urothelial carcinoma: a prospective study.11C-胆碱与 18F-FDG 在正电子发射断层扫描/计算机断层扫描中对尿路上皮癌分期的比较:一项前瞻性研究。
J Urol. 2011 Aug;186(2):436-41. doi: 10.1016/j.juro.2011.03.121. Epub 2011 Jun 15.
10
[The (11C) acetate positron emission tomography in prostatic carcinoma. New prospects in metabolic imaging].[(11C)乙酸盐正电子发射断层扫描在前列腺癌中的应用。代谢成像的新前景]
Urologe A. 2002 Nov;41(6):569-76. doi: 10.1007/s00120-002-0244-9.

引用本文的文献

1
Cancer of unknown primary eventually diagnosed as poorly differentiated prostate cancer: a case report.不明原发灶癌最终诊断为低分化前列腺癌:病例报告。
J Med Case Rep. 2023 Sep 3;17(1):376. doi: 10.1186/s13256-023-04118-2.
2
In vivo tissue pharmacokinetics of ERBB2-specific binding oligonucleotide-based drugs by PET imaging.采用 PET 成像技术研究 ERBB2 特异性结合寡核苷酸类药物的体内组织药代动力学。
Clin Transl Sci. 2023 Jul;16(7):1186-1196. doi: 10.1111/cts.13522. Epub 2023 Apr 20.
3
PARP Inhibitors and Radiometabolic Approaches in Metastatic Castration-Resistant Prostate Cancer: What's Now, What's New, and What's Coming?
PARP抑制剂与放射性代谢方法在转移性去势抵抗性前列腺癌中的应用:现状、新进展与未来趋势?
Cancers (Basel). 2022 Feb 11;14(4):907. doi: 10.3390/cancers14040907.
4
Multimodal Imaging-Based Potential Visualization of the Tumor Microenvironment in Bone Metastasis.基于多模态影像学的骨转移肿瘤微环境潜在可视化
Cells. 2021 Oct 25;10(11):2877. doi: 10.3390/cells10112877.
5
Molecular Imaging in Primary Staging of Prostate Cancer Patients: Current Aspects and Future Trends.前列腺癌患者初始分期中的分子成像:当前现状与未来趋势
Cancers (Basel). 2021 Oct 26;13(21):5360. doi: 10.3390/cancers13215360.
6
Fluorodeoxyglucose versus Choline Positron Emission Tomography/Computed Tomography Response Evaluation in Two Malignant Pleural Mesothelioma Patients Treated with Talc Pleurodesis and Neoadjuvant Chemotherapy.两名接受滑石胸膜固定术和新辅助化疗的恶性胸膜间皮瘤患者中氟脱氧葡萄糖与胆碱正电子发射断层扫描/计算机断层扫描反应评估
Cureus. 2018 Nov 28;10(11):e3654. doi: 10.7759/cureus.3654.
7
Overcoming tumor hypoxia as a barrier to radiotherapy, chemotherapy and immunotherapy in cancer treatment.克服肿瘤乏氧作为癌症治疗中放疗、化疗和免疫治疗的障碍。
Int J Nanomedicine. 2018 Oct 4;13:6049-6058. doi: 10.2147/IJN.S140462. eCollection 2018.
8
Diagnostic performance of choline PET/CT for the detection of bone metastasis in prostate cancer: A systematic review and meta-analysis.胆碱 PET/CT 检测前列腺癌骨转移的诊断性能:系统评价和荟萃分析。
PLoS One. 2018 Sep 7;13(9):e0203400. doi: 10.1371/journal.pone.0203400. eCollection 2018.
9
Loss of Sun2 promotes the progression of prostate cancer by regulating fatty acid oxidation.Sun2缺失通过调节脂肪酸氧化促进前列腺癌进展。
Oncotarget. 2017 Jul 12;8(52):89620-89630. doi: 10.18632/oncotarget.19210. eCollection 2017 Oct 27.
10
Diagnostic performance of C-choline PET/CT and bone scintigraphy in the detection of bone metastases in patients with prostate cancer.C-胆碱PET/CT与骨闪烁显像对前列腺癌患者骨转移灶的诊断效能
Nagoya J Med Sci. 2017 Aug;79(3):387-399. doi: 10.18999/nagjms.79.3.387.